Trastuzumab deruxtecan induces durable responses in HER2-mutated NSCLC

Press/Media

Period	18 Sep 2021

Media coverage

Title	Trastuzumab deruxtecan induces durable responses in HER2-mutated NSCLC
Media name/outlet	Healio
Country/Territory	United States
Date	18/09/21
URL	https://www.healio.com/news/hematology-oncology/20210918/trastuzumab-deruxtecan-induces-durable-responses-in-her2mutated-nsclc
Persons	Fred Hirsch, Fred Hirsch